← back to search

Manting Liu

Guangzhou University of Chinese Medicine · CN
🔎 Find collaborators in Oncology · Applied Mathematics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Applied Mathematics
Research interest
Research interests include Medicine, Cancer research, Chimeric antigen receptor, Adverse effect, Immunotherapy, and Ovarian cancer.
h-index
citations
565
works
16
NIH funding
primary concept
email

Recent publications

Global knowledge graph of osteoporosis biomarkers based on large language model embeddings and complex network algorithms
Frontiers in Endocrinology 2026cited by 0position: middledoi
Systematic analysis and prediction of the burden of Alzheimer’s disease and other dementias caused by hyperglycemia
Frontiers in Public Health 2025cited by 9position: middledoi
Shengxue Busui Decoction activates the PI3K/Akt and VEGF pathways, enhancing vascular function and inhibiting osteocyte apoptosis to combat steroid-induced femoral head necrosis
Frontiers in Pharmacology 2025cited by 6position: firstdoi
Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance
Expert Opinion on Drug Safety 2025cited by 5position: middledoi
Drug-induced pulmonary edema: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS)
Brazilian Journal of Medical and Biological Research 2025cited by 0position: middledoi
Intratumoral delivery of PD-1/PD-L1 and CTLA-4 inhibitors for recurrent/refractory solid tumors: a proof-of-concept treatment strategy
Frontiers in Immunology 2025cited by 0position: middledoi
NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer
International Journal of Biological Sciences 2024cited by 28position: middledoi
Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma
Journal of Leukocyte Biology 2024cited by 17position: lastdoi
Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database
Medicine 2024cited by 14position: middledoi
Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
Expert Opinion on Drug Safety 2024cited by 5position: middledoi
Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation
Genomics 2024cited by 3position: middledoi
Adverse reaction of specific acute kidney injury caused by atorvastatin: an actual study based on the database of the US FDA adverse event reporting system
Expert Opinion on Drug Safety 2024cited by 0position: middledoi
Effective sequential combined therapy with carboplatin and a CDC7 inhibitor in ovarian cancer
Translational Oncology 2023cited by 4position: middledoi
Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer
Nature Communications 2022cited by 103position: middledoi
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
Journal of Hematology & Oncology 2021cited by 282position: middledoi
Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer
Biochemical and Biophysical Research Communications 2020cited by 89position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dongqiang Luo · Guangzhou University of Chinese Medicine6 papers (2024–2025)Zhenfeng Zhang · Southern University of Science and Technology5 papers (2020–2025)Bihui Cao · Indiana University School of Medicine5 papers (2020–2024)Xiaodie Ye · Guangzhou Medical University4 papers (2020–2024)Hui Lian · Guangzhou Medical University4 papers (2022–2025)Qingde Wu · Guangzhou University of Chinese Medicine4 papers (2020–2025)Xiangyun Dou · Guangzhou University of Chinese Medicine3 papers (2024–2025)Shulan Huang · Southern Medical University3 papers (2024–2025)Jiazhen Jiang · Fudan University3 papers (2024–2025)Jiayu Wu · Guangzhou University of Chinese Medicine3 papers (2024–2025)Dongni Chen · Nanfang Hospital3 papers (2023–2025)Shuo Yang · China University of Geosciences (Beijing)3 papers (2022–2024)Cheng Zhi · University of Science and Technology of China3 papers (2020–2024)Bingjia He · Guangzhou Medical University2 papers (2024–2025)Jiyuan Zheng · Guangzhou University of Chinese Medicine2 papers (2024–2024)Zhiru Zhang · Cornell University2 papers (2022–2023)Rom S. Leidner · Providence Health & Services2 papers (2024–2025)Yuling Hu · Chengdu Women's and Children's Central Hospital2 papers (2023–2024)Lu Wang · Guangzhou Medical University2 papers (2020–2022)Lili Yang · Kunming University2 papers (2023–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Applied Mathematics →